» Articles » PMID: 26301223

Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis

Overview
Specialty General Medicine
Date 2015 Aug 25
PMID 26301223
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Renal proximal tubular cells are the most energy-demanding cells in the body. The ATP that they use is mostly produced in their mitochondrial and peroxisomal compartments, by the oxidation of fatty acids. When those cells are placed under a biological stress, such as a transient hypoxia, fatty acid oxidation (FAO) is shut down for a period of time that outlasts injury, and carbohydrate oxidation does not take over. Facing those metabolic constraints, surviving tubular epithelial cells exhibit a phenotypic switch that includes cytoskeletal rearrangement and production of extracellular matrix proteins, most probably contributing to acute kidney injury-induced renal fibrogenesis, thence to the development of chronic kidney disease. Here, we review experimental evidence that dysregulation of FAO profoundly affects the fate of tubular epithelial cells, by promoting epithelial-to-mesenchymal transition, inflammation, and eventually interstitial fibrosis. Restoring physiological production of energy is undoubtedly a possible therapeutic approach to unlock the mesenchymal reprograming of tubular epithelial cells in the kidney. In this respect, the benefit of the use of fibrates is uncertain, but new drugs that could specifically target this metabolic pathway, and, hopefully, attenuate renal fibrosis merit future research.

Citing Articles

Membranous Nephropathy.

Ponticelli C J Clin Med. 2025; 14(3).

PMID: 39941432 PMC: 11818350. DOI: 10.3390/jcm14030761.


Lipidomics-based natural products for chronic kidney disease treatment.

Zhang R, Wang J, Wu C, Wang L, Liu P, Li P Heliyon. 2025; 11(1):e41620.

PMID: 39866478 PMC: 11758422. DOI: 10.1016/j.heliyon.2024.e41620.


From Adipose to Ailing Kidneys: The Role of Lipid Metabolism in Obesity-Related Chronic Kidney Disease.

Xu W, Zhu Y, Wang S, Liu J, Li H Antioxidants (Basel). 2025; 13(12.

PMID: 39765868 PMC: 11727289. DOI: 10.3390/antiox13121540.


Obesity-Related Kidney Disease in Bariatric Surgery Candidates.

Pereira P, Almeida M, Braga P, Pereira J, Pereira S, Nora M Obes Surg. 2024; 35(1):181-188.

PMID: 39636519 PMC: 11717886. DOI: 10.1007/s11695-024-07602-w.


Metabolic Chaos in Kidney Disease: Unraveling Energy Dysregulation.

Gupta P, Zhu S, Gui Y, Zhou D J Clin Med. 2024; 13(22).

PMID: 39597916 PMC: 11594442. DOI: 10.3390/jcm13226772.


References
1.
Okamura D, Pennathur S, Pasichnyk K, Lopez-Guisa J, Collins S, Febbraio M . CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD. J Am Soc Nephrol. 2009; 20(3):495-505. PMC: 2653683. DOI: 10.1681/ASN.2008010009. View

2.
Portilla D . Role of fatty acid beta-oxidation and calcium-independent phospholipase A2 in ischemic acute renal failure. Curr Opin Nephrol Hypertens. 1999; 8(4):473-7. DOI: 10.1097/00041552-199907000-00012. View

3.
Chung H, Lim J, Kim M, Shin S, Chung S, Choi B . High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway. Nephrol Dial Transplant. 2011; 27(6):2213-25. DOI: 10.1093/ndt/gfr613. View

4.
Colvin R . Chronic allograft nephropathy. N Engl J Med. 2003; 349(24):2288-90. DOI: 10.1056/NEJMp038178. View

5.
Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M . Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes. 2006; 55(9):2502-9. DOI: 10.2337/db05-0603. View